Bhatia Kishor G. 4
4 · Lantern Pharma Inc. · Filed Dec 22, 2025
Insider Transaction Report
Form 4
Bhatia Kishor G.
Chief Scientific Officer
Transactions
- Award
Stock Option (Right to Buy)
2025-12-18+10,000→ 10,000 totalExercise: $3.24Exp: 2035-12-17→ Common Stock (10,000 underlying)
Footnotes (1)
- [F1]The Options are granted under the Lantern Pharma Inc. Amended and Restated 2018 Stock Incentive Plan. The Options shall vest and first become exercisable in equal monthly increments over a 24-month period commencing January 18, 2026.